57 related articles for article (PubMed ID: 19787276)
1. Promoter hypermethylation of the p16 and Wif-1 genes as an independent prognostic marker in stage IA non-small cell lung cancers.
Yoshino M; Suzuki M; Tian L; Moriya Y; Hoshino H; Okamoto T; Yoshida S; Shibuya K; Yoshino I
Int J Oncol; 2009 Nov; 35(5):1201-9. PubMed ID: 19787276
[TBL] [Abstract][Full Text] [Related]
2. Polymerase chain reaction - surface-enhanced Raman spectroscopy (PCR-SERS) method for gene methylation level detection in plasma.
Li X; Yang T; Li CS; Song Y; Wang D; Jin L; Lou H; Li W
Theranostics; 2020; 10(2):898-909. PubMed ID: 31903158
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the utility of
Nakasone ES; Zemla TJ; Yu M; Lin SY; Ou FS; Carter K; Innocenti F; Saltz L; Grady WM; Cohen SA
Epigenetics; 2024 Dec; 19(1):2349980. PubMed ID: 38716804
[TBL] [Abstract][Full Text] [Related]
4. Promoter Hypermethylation of Wnt/β-catenin Signaling Pathway Inhibitor
Jalilvand A; Soltanpour MS
Oman Med J; 2020 May; 35(3):e131. PubMed ID: 32607254
[TBL] [Abstract][Full Text] [Related]
5. Cytological examination of pleural cavity lavage accompanied by the study of gene promoter hypermethylation of p16 and O6-methylguanine-DNA-methyltransferase genes in diagnostics of non-small cell lung cancer metastatic changes into pleura.
Kaczmarczyk G; Lewandowski R; Trautsolt W; Ziółkowski A; Kozielski J
Contemp Oncol (Pozn); 2012; 16(4):322-7. PubMed ID: 23788902
[TBL] [Abstract][Full Text] [Related]
6. TMPRSS4: A Novel Tumor Prognostic Indicator for the Stratification of Stage IA Tumors and a Liquid Biopsy Biomarker for NSCLC Patients.
Villalba M; Exposito F; Pajares MJ; Sainz C; Redrado M; Remirez A; Wistuba I; Behrens C; Jantus-Lewintre E; Camps C; Montuenga LM; Pio R; Lozano MD; de Andrea C; Calvo A
J Clin Med; 2019 Dec; 8(12):. PubMed ID: 31817025
[TBL] [Abstract][Full Text] [Related]
7. Anti proliferative and apoptotic effects on pancreatic cancer cell lines indicate new roles for ANGPTL8 (Betatrophin).
Taherkhani F; Hosseini KM; Zebardast S; Chegini KG; Gheibi N
Genet Mol Biol; 2020 Jul; 43(3):e20190196. PubMed ID: 32745158
[TBL] [Abstract][Full Text] [Related]
8. Association between SFRP promoter hypermethylation and different types of cancer: A systematic review and meta-analysis.
Yu J; Xie Y; Li M; Zhou F; Zhong Z; Liu Y; Wang F; Qi J
Oncol Lett; 2019 Oct; 18(4):3481-3492. PubMed ID: 31516566
[TBL] [Abstract][Full Text] [Related]
9. Hypermethylation of WIF1 and its inhibitory role in the tumor growth of endometrial adenocarcinoma.
Deng X; Hou C; Wang H; Liang T; Zhu L
Mol Med Rep; 2017 Nov; 16(5):7497-7503. PubMed ID: 28944908
[TBL] [Abstract][Full Text] [Related]
10. Reprimo, a Potential p53-Dependent Tumor Suppressor Gene, Is Frequently Hypermethylated in Estrogen Receptor α-Positive Breast Cancer.
Buchegger K; Riquelme I; Viscarra T; Ili C; Brebi P; Huang TH; Roa JC
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28809778
[TBL] [Abstract][Full Text] [Related]
11. Wnt inhibitory factor 1 (WIF1) methylation and its association with clinical prognosis in patients with chondrosarcoma.
Liu P; Shen JK; Hornicek FJ; Liu F; Duan Z
Sci Rep; 2017 May; 7(1):1580. PubMed ID: 28484252
[TBL] [Abstract][Full Text] [Related]
12. Promoter hypermethylation of Wnt inhibitory factor-1 in patients with lung cancer: A systematic meta-analysis.
Zheng Y; Li X; Jiang Y; Xu Y; Song B; Zhou Q; Liang X; Yang X
Medicine (Baltimore); 2016 Dec; 95(49):e5433. PubMed ID: 27930522
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological significance of WIF1 hypermethylation in NSCLC, a meta-analysis and literature review.
Guo H; Zhou S; Tan L; Wu X; Wu Z; Ran R
Oncotarget; 2017 Jan; 8(2):2550-2557. PubMed ID: 27911280
[TBL] [Abstract][Full Text] [Related]
14. The triptolide derivative MRx102 inhibits Wnt pathway activation and has potent anti-tumor effects in lung cancer.
Reno TA; Tong SW; Wu J; Fidler JM; Nelson R; Kim JY; Raz DJ
BMC Cancer; 2016 Jul; 16():439. PubMed ID: 27400883
[TBL] [Abstract][Full Text] [Related]
15. Reprimo as a modulator of cell migration and invasion in the MDA-MB-231 breast cancer cell line.
Buchegger K; Ili C; Riquelme I; Letelier P; Corvalán AH; Brebi P; Huang TH; Roa JC
Biol Res; 2016 Jan; 49():5. PubMed ID: 26796959
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological significance and potential drug target of RUNX3 in non-small cell lung cancer: a meta-analysis.
Xu L; Lan H; Su Y; Li J; Wan J
Drug Des Devel Ther; 2015; 9():2855-65. PubMed ID: 26082616
[TBL] [Abstract][Full Text] [Related]
17. Alterations in DNA methylation may be the key to early detection and treatment of schistosomal bladder cancer.
Conti SL; Honeycutt J; Odegaard JI; Gonzalgo ML; Hsieh MH
PLoS Negl Trop Dis; 2015 Jun; 9(6):e0003696. PubMed ID: 26042665
[No Abstract] [Full Text] [Related]
18. The negative regulators of Wnt pathway-DACH1, DKK1, and WIF1 are methylated in oral and oropharyngeal cancer and WIF1 methylation predicts shorter survival.
Paluszczak J; Sarbak J; Kostrzewska-Poczekaj M; Kiwerska K; Jarmuż-Szymczak M; Grenman R; Mielcarek-Kuchta D; Baer-Dubowska W
Tumour Biol; 2015 Apr; 36(4):2855-61. PubMed ID: 25487617
[TBL] [Abstract][Full Text] [Related]
19. Association between RUNX3 promoter methylation and non-small cell lung cancer: a meta-analysis.
Liang Y; He L; Yuan H; Jin Y; Yao Y
J Thorac Dis; 2014 Jun; 6(6):694-705. PubMed ID: 24976992
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
